Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Moia

Showing results (11-20 of 51) with videos related to

Pageof 6
Sort By:
Thrombosis and Haemostasis|September 1, 1994
A pilot study of pro-urokinase in the treatment of deep vein thrombosisM Moia, P M Mannucci, M Pini, et al.
International Journal of Clinical & Laboratory Research|January 1, 1993
Ischemic stroke in congenital (type II C) defective antithrombin IIII Martinelli, M Moia, A Arbini, et al.
Thrombosis and Haemostasis|September 24, 1999
High levels of tissue factor pathway inhibitor in patients with nephrotic proteinuriaR A Ariëns, M Moia, E Rivolta, et al.
Blood|November 1, 1989
DDAVP shortens the prolonged bleeding times of patients with severe von Willebrand disease treated with cryoprecipitate. Evidence for a mechanism of action independent of released von Willebrand factorM Cattaneo, M Moia, P Delle Valle, et al.
Thrombosis and Haemostasis|August 26, 1998
Congenital resistance to activated protein C in patients with lupus anticoagulants: evaluation of two functional assaysM Galli, F Duca, L Ruggeri, et al.
Thrombosis and Haemostasis|August 2, 1993
Effects of hirudin on activated partial thromboplastin time determined with ten different reagentsA Tripodi, V Chantarangkul, A A Arbini, et al.
Lancet (London, England)|November 28, 1987
Improvement in the haemostatic defect of uraemia after treatment with recombinant human erythropoietinM Moia, P M Mannucci, L Vizzotto, et al.
Journal of Hepatology|May 1, 1992
Prognostic value of hemostatic parameters after liver transplantationM Moia, I Martinelli, B Gridelli, et al.
American Journal of Hematology|May 1, 1987
Correction of the bleeding time in treated patients with severe von Willebrand disease is not solely dependent on the normal multimeric structure of plasma von Willebrand factorP M Mannucci, M Moia, P Rebulla, et al.
Haematologica|October 17, 2001
Effect of computer-aided management on the quality of treatment in anticoagulated patients: a prospective, randomized, multicenter trial of APROAT (Automated PRogram for Oral Anticoagulant Treatment)C Manotti, M Moia, G Palareti, et al.
Pageof 6

Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
Thrombosis and Haemostasis|September 1, 1994
A pilot study of pro-urokinase in the treatment of deep vein thrombosisM Moia, P M Mannucci, M Pini, et al.
International Journal of Clinical & Laboratory Research|January 1, 1993
Ischemic stroke in congenital (type II C) defective antithrombin IIII Martinelli, M Moia, A Arbini, et al.
Thrombosis and Haemostasis|September 24, 1999
High levels of tissue factor pathway inhibitor in patients with nephrotic proteinuriaR A Ariëns, M Moia, E Rivolta, et al.
Blood|November 1, 1989
DDAVP shortens the prolonged bleeding times of patients with severe von Willebrand disease treated with cryoprecipitate. Evidence for a mechanism of action independent of released von Willebrand factorM Cattaneo, M Moia, P Delle Valle, et al.
Thrombosis and Haemostasis|August 26, 1998
Congenital resistance to activated protein C in patients with lupus anticoagulants: evaluation of two functional assaysM Galli, F Duca, L Ruggeri, et al.
Thrombosis and Haemostasis|August 2, 1993
Effects of hirudin on activated partial thromboplastin time determined with ten different reagentsA Tripodi, V Chantarangkul, A A Arbini, et al.
Lancet (London, England)|November 28, 1987
Improvement in the haemostatic defect of uraemia after treatment with recombinant human erythropoietinM Moia, P M Mannucci, L Vizzotto, et al.
Journal of Hepatology|May 1, 1992
Prognostic value of hemostatic parameters after liver transplantationM Moia, I Martinelli, B Gridelli, et al.
American Journal of Hematology|May 1, 1987
Correction of the bleeding time in treated patients with severe von Willebrand disease is not solely dependent on the normal multimeric structure of plasma von Willebrand factorP M Mannucci, M Moia, P Rebulla, et al.
Haematologica|October 17, 2001
Effect of computer-aided management on the quality of treatment in anticoagulated patients: a prospective, randomized, multicenter trial of APROAT (Automated PRogram for Oral Anticoagulant Treatment)C Manotti, M Moia, G Palareti, et al.
Pageof 6